Studies have shown that ITGB6 was a liver-metastasis-related gene for PAAD patients (39) and the overexpression of ITGB6 was significantly associated with advanced AJCC stage and histologic grade, and worse prognosis in pancreatic cancer (40). This evidence concerns the gene ITGB6 and pancreatic adenocarcinoma.